KE
Keller Eric L. disclosed a 7.1% stake in RTSN
Keller Eric L. reported owning 7.1% of Retension Pharmaceuticals, Inc. (RTSN) (598,598 shares) in a Schedule 13D filed Oct 14, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 14, 2026
- Source
- Schedule 13D